Clinical Trial Update: The Efficacy and Safety of Combining Probiotic VSL#3 With Vedolizumab for the Treatment of Moderate Ulcerative Colitis [Phase 4]

View source ↗

Summary

This document provides an update on a Phase 4 clinical trial evaluating the combination of the probiotic VSL#3 with Vedolizumab for moderate ulcerative colitis,…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ulcerative Colitis

Drugs mentioned

• VSL#3
• Vedolizumab (vedolizumab)

Snippet

Sponsor: Second Affiliated Hospital, School of Medicine, Zhejiang University | Conditions: Ulcerative Colitis | Phase 4 | Status: RECRUITING